在风险较高的人群中进行氧化二期试验
Kevin D Deane1, Christopher C Striebich1, Marie L Feser1
1University of Colorado School of Medicine Anschutz Medical Campus, Aurora, Colorado.
Arthritis & rheumatology (Hoboken, N.J.)
|August 30, 2025
概括
在具有高抗CCP抗体的风险人群中,基 (HCQ) 没有预防类风湿性关节炎 (RA). 这项为期12个月的试验在36个月的HCQ和安慰剂组之间没有发现RA发展的显著差异.
科学领域:
- 关节病学
- 免疫学
- 临床试验
背景情况:
- 抗循环抗体 (抗CCP) 增加的人面临患类风湿性关节炎 (RA) 的更高风险.
- 没有批准的药物治疗方法可以预防这种风险人群的RA.
- 在没有可靠的临床试验数据的情况下,Hydroxychloroquine (HCQ) 有时用于RA预防.
研究的目的:
- 评估基 (HCQ) 预防临床类风湿性关节炎 (RA) 的有效性.
- 评估HCQ在这个人群中的安全性和耐受性.
主要方法:
- 一个2期随机试验,涉及至少高于正常值上限 (ULN) 两倍的抗CCP水平.
- 参与者接受HCQ或安慰剂治疗12个月,随访时间长达36个月.
- 主要结局是临床RA的发展;次要结局包括炎症性关节炎和参与者报告的症状.
主要成果:
- 临床关节炎发生在HCQ组的30. 4%,而安慰剂组的32. 9% (P=0. 52).
- 在临床关节炎,炎症性关节炎或关节症状的风险上没有显著差异.
- 在两组治疗中,不良事件发生率和严重程度相似.
结论:
- 在抗CCP抗体升高的个体中,十二个月的氧化 (HCQ) 治疗没有预防临床类风湿性关节炎 (RA) 的发展.
- 这项研究不支持HCQ用于预防这种风险群体的RA.
相关概念视频
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
57
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57
Phase II Reactions: Glucuronidation
767
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
767
Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
Rheumatic Heart Disease I: Introduction
38
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
38


